Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000378762 | SCV000373429 | uncertain significance | Autosomal dominant cerebellar ataxia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004021520 | SCV004957127 | uncertain significance | Inborn genetic diseases | 2024-02-05 | criteria provided, single submitter | clinical testing | The c.476G>A (p.R159Q) alteration is located in exon 4 (coding exon 3) of the SPTBN2 gene. This alteration results from a G to A substitution at nucleotide position 476, causing the arginine (R) at amino acid position 159 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |